People: Vanda Pharmaceuticals Inc (VNDA.O)

VNDA.O on Consolidated Issue listed on NASDAQ Global Market

12.58USD
21 Nov 2014
Price Change (% chg)

$0.59 (+4.92%)
Prev Close
$11.99
Open
$12.22
Day's High
$12.65
Day's Low
$12.05
Volume
697,427
Avg. Vol
602,051
52-wk High
$19.25
52-wk Low
$8.34

Search Stocks

Watkins, H. Thomas 

Brief Biography

Mr. H. Thomas Watkins serves as Independent Director of Vanda Pharmaceuticals Inc., since September 2006. Mr. Watkins has served as the President and Chief Executive Officer of Human Genome Sciences, Inc. and as a member of its Board of Directors from 2005 until August 2012, when Human Genome Sciences, Inc. was acquired by GlaxoSmithKline. Prior to his tenure at Human Genome Sciences, Inc., Mr. Watkins served as President of TAP Pharmaceutical Products, Inc. Mr. Watkins previously held a series of executive positions over the course of nearly twenty years with Abbott Laboratories. Mr. Watkins also serves on the Board of Directors of the Biotechnology Industry Organization (“BIO”), and has served as Chair of the BIO Board of Directors since June, 2011. He holds a B.B.A. from the College of William and Mary and an M.B.A from the University of Chicago Graduate School of Business.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Howard Pien

--

Mihael Polymeropoulos

2,520,230

James Kelly

1,145,380

Paolo Baroldi

1,111,410

Michael Cola

--

Richard Dugan

--
As Of 30 Dec 2013
Search Stocks